- Home
- GERN vs EQBK Comparison
GERN vs EQBK Comparison
Compare GERN & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GERN | EQBK |
|---|---|---|
| Founded | 1990 | 2002 |
| Country | United States | United States |
| Employees | 229 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 870.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | GERN | EQBK |
|---|---|---|
| Price | $1.58 | $43.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $2.17 | ★ $50.50 |
| AVG Volume (30 Days) | ★ 16.9M | 96.3K |
| Earning Date | 05-06-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | N/A | N/A |
| Revenue This Year | $26.91 | $74.58 |
| Revenue Next Year | $43.75 | $5.11 |
| P/E Ratio | ★ N/A | $35.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $34.11 |
| 52 Week High | $2.01 | $50.07 |
Technical Indicators
Market Signals| Indicator | GERN | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 41.57 |
| Support Level | $1.24 | $42.84 |
| Resistance Level | $1.70 | $44.50 |
| Average True Range (ATR) | 0.11 | 1.11 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 57.81 | 35.95 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.